-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease.
-
Summary
-
Lineage Cell Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q2 2019 to Q2 2022.
- Lineage Cell Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending June 30, 2022 was $2.38M.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)